In contrast, the overall fibrillary collagen content was visibly reduced in tumors from mice that received TGFβ-blocking antibodies, with dispersed fibers arranged in disorganized bundles, demonstrating that TGFβ-blockade impairs myofibroblast functions, leading to destabilization of the tumor collagen framework. The gene discussed is TGFB1; the disease is neoplasm.